 |
|
Abnormalities in CNS Monoamine Metabolism in Anorexia Nervosa
Walter H. Kaye, MD;
Michael H. Ebert, MD;
Michael Raleigh, PhD;
C. Raymond Lake, MD
Arch Gen Psychiatry. 1984;41(4):350-355.
Abstract
• Patients with anorexia nervosa have disturbances of mood, appetite, and neuroendocrine function. Central nervous system monoamine pathways modulate these systems, and alterations in function of these systems may occur in anorexia nervosa. Because monoamine metabolism can be influenced by nutritional intake, we studied anorectics before and at intervals after correction of weight loss. Underweight anorectics had a 30% decrease in CSF homovanillic acid level and a 20% decrease in CSF 5-hydroxyindoleacetic acid concentration; these values returned to normal shortly after weight recovery. The CSF level of norepinephrine (NE) in underweight anorectics and in these patients a few weeks after weight restoration was similar to that in normal subjects. Long-term weight-recovered (20 ± 7 months) anorectics, however, had a 50% decrease in CSF NE level compared with that of controls. Underweight anorectics have state-associated disturbances in dopamine and serotonin metabolism. Changes in NE metabolism are more complex and state independent. These abnormalities in neurotransmitter metabolism are part of the neurobiological syndrome of anorexia nervosa and may contribute to the characteristic changes in mood, behavior, and neuroendocrine function.
Author Affiliations
From the Intramural Research Program, National Institute of Mental Health, Bethesda, Md (Drs Kaye and Ebert); the Department of Psychiatry, UCLA School of Medicine, Los Angeles (Dr Raleigh); and the Departments of Psychiatry and Pharmacology, Uniformed Services University of the Health Sciences School of Medicine, Bethesda, Md (Dr Lake).
Footnotes
Accepted for publication July 15, 1983.
Reprint requests to Bldg 10, Room 4C110, Laboratory of Psychology and Psychopathology, National Institute of Mental Health, Bethesda, MD 20205 (Dr Kaye).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Endocrine Dysregulation in Anorexia Nervosa Update
Miller
J. Clin. Endocrinol. Metab. 2011;96:2939-2949.
ABSTRACT
| FULL TEXT
The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia
Hillebrand et al.
J Mol Endocrinol 2006;36:153-162.
ABSTRACT
| FULL TEXT
Serotonergic and Dopaminergic Systems in Anorexia Nervosa: A Role for Atypical Antipsychotics?
Bosanac et al.
Aust N Z J Psychiatry 2005;39:146-153.
ABSTRACT
| FULL TEXT
Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome
Thumshirn et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 1998;275:G314-G321.
ABSTRACT
| FULL TEXT
Cerebrospinal Fluid Leptin in Anorexia Nervosa: Correlation with Nutritional Status and Potential Role in Resistance to Weight Gain
Mantzoros et al.
J. Clin. Endocrinol. Metab. 1997;82:1845-1851.
ABSTRACT
| FULL TEXT
Altered Serotonin Activity in Anorexia Nervosa After Long-term Weight Restoration: Does Elevated Cerebrospinal Fluid 5-Hydroxyindoleacetic Acid Level Correlate With Rigid and Obsessive Behavior?
Kaye et al.
Arch Gen Psychiatry 1991;48:556-562.
ABSTRACT
Altered Cerebrospinal Fluid Neuropeptide Y and Peptide YY Immunoreactivity in Anorexia and Bulimia Nervosa
Kaye et al.
Arch Gen Psychiatry 1990;47:548-556.
ABSTRACT
The Effects of Dieting and Weight Loss on Neuroendocrine Responses to Tryptophan, Clonidine, and Apomorphine in Volunteers: Important Implications for Neuroendocrine Investigations in Depression
Goodwin et al.
Arch Gen Psychiatry 1987;44:952-957.
ABSTRACT
Effects of Antidepressant Treatments on Platelet Tritiated Imipramine Binding in Major Depressive Disorder
Wagner et al.
Arch Gen Psychiatry 1987;44:870-877.
ABSTRACT
|
